Degarelix for the treatment of advanced prostate cancer compared with GnRh-Agonists: a systematic review and meta-analysis.

Hosseini, Seyed Alireza; Rajabi, Fatemeh; Akbari Sari, Ali; Ayati, Mohsen; Heidari, Saeed; Ghamary, Fawzieh

Hosseini, Seyed Alireza; Rajabi, Fatemeh; Akbari Sari, Ali; Ayati, Mohsen; Heidari, Saeed; Ghamary, Fawzieh.

Afiliação

Hosseini SA; Associate Professor, Food and Drug Research Center, Clinical Trials Group, Iran Food and Drug Administration, Tehran, Iran. a.hosseini@fda.gov.ir .
Rajabi F; Assistant Professor in Community Medicine, Community Based Participatory Research Center, Iranian Institute for Reduction of High-Risk Behaviors, & Center for Academic and Health Policy, Tehran University of Medical Sciences, Tehran, Iran. frajabi@tums.ac.ir.
Akbari Sari A; Associate Professor, Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. akbarisari@tums.ac.ir .
Ayati M; Associate Professor of Urology, Department of Urology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran. drayati_mohsen@yahoo.com .
Heidari S; MSc, Health Technology Assessment, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. saeedheidari.hta@gmail.com.
Ghamary F; MSc, Health Technology Assessment, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. fgh12@ymail.com .

Med J Islam Repub Iran ; 30: 317, 2016.

Article em En | MEDLINE | ID: mdl-27390687

Palavras-chave

Degarelix; Efficacy; GnRH Agonists; Goserelin; Leuprolide; Meta-analysis; Prostate cancer; Safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google